The Center for Cancer Research's Proteomics Shared Resource is a new Shared Resource that combines various proteomic services (global proteomic, protein identification, and single protein analysis) in a single facility to better serve the needs of the Center for Cancer Research members. The Proteomics Shared Resource is distinguished from the Mass Spectrometry Shared Resource, which focuses on the analysis of small organic compounds to primarily support chemistry-driven projects in the Medicinal Chemistry and Drug Delivery and Molecular Sensing scientific programs. The advanced instrumentation in the Proteomic Shared Resource supports: 1) the high throughput analysis of biological fluids and tissue extracts;2) the identification of proteins in cellular complexes;and 3) the analysis of protein modifications. The Shared Resource is directed by Dr. Fred Regnier, the J. H. Law Distinguished Professor of Chemistry who has over 30 years experience as a leader in the field of applied mass spectrometry technology. Dr. Regnier is ideally suited to direct this new Shared Resource and to guide and facilitate new avenues of investigation by Center for Cancer Research members who may not be familiar with the capabilities the instrumentation the new facility offers.
The role of the shared resource is to assist individual investigators and scientific Programs within the Center that are seeking novel approaches to addressing a variety of cancer-related issues. In offering these key services, the shared resource provides the expertise necessary for achieving the next challenge;challenges that when solved will aid in reducing the pain and suffering of cancer.
|Onel, Buket; Carver, Megan; Agrawal, Prashansa et al. (2018) The 3'-end region of the human PDGFR-? core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes. Biochim Biophys Acta Gen Subj 1862:846-854|
|Sorlien, Erin L; Witucki, Mary A; Ogas, Joseph (2018) Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio. J Vis Exp :|
|Mani, Saravana Kumar Kailasam; Andrisani, Ourania (2018) Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine :|
|Dong, Cheng; Dong, Guangping; Li, Li et al. (2018) An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2. Commun Biol 1:183|
|Morman, Rosemary E; Schweickert, Patrick G; Konieczny, Stephen F et al. (2018) BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice. Eur J Immunol 48:1492-1505|
|Zhang, Zhuangzhuang; Cheng, Lijun; Li, Jie et al. (2018) Inhibition of the Wnt/?-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Res 78:3147-3162|
|Rangasamy, Loganathan; Chelvam, Venkatesh; Kanduluru, Ananda Kumar et al. (2018) New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. Bioconjug Chem 29:1047-1059|
|Zhang, Hao; Zhang, Yanqiu; Zhu, Xiaoyun et al. (2018) DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology :|
|Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985|
|Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112|
Showing the most recent 10 out of 436 publications